Simulations Plus, Inc. — Company profile
Healthcare · Health Information Services · United States
Last price 18.5 USD (At close: Oct 5, 2026) · Market cap 374.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Details
| Name | Simulations Plus, Inc. |
| Sector | Healthcare |
| Industry | Health Information Services |
| Employees | 213 |
| Founded | 1996 |
| Ipo Date | 1997-06-18 |
| Ceo | Shawn O'Connor |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| Isin | US8292141053 |
| Cusip | 829214105 |
| Cik | 0001023459 |
| Sic | 7373 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Shawn M. O'Connor | Chief Executive Officer |
| William Frederick | Chief Financial Officer, Executive Vice President and Corporate Secretary |
| Joshua Fohey | Chief Operating Officer |
| John Anthony DiBella M.S. | Chief Revenue Officer |
| Jill Fiedler-Kelly M.S. | President of Services Solutions |
| Steven Chang | Global Head of Strategic Alliances |
| Jennifer Presnell | Accounting Manager |
| Viera Lukacova Ph.D. | Chief Science Officer |
| Dr. Bud Nelson J.D., Ph.D. | Vice President, Corporate Counsel and Personal Data Protection Officer |
| Christina Hendrickson | Senior Director of Corporate Marketing |
Contact
| Address | 800 Park Offices Drive, Suite 401, Research Triangle Park, North Carolina 27709, United States |
| Phone | 661 723 7723 |
| Website | https://www.simulations-plus.com |